ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Pulmonary Disease

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

9,741Medicare Part D Prescriptions Filled, Including Refills

Rank: 3 out of 241

$747K Total Retail Price of All Prescriptions

Rank: 25 out of 241

296 Patients Receiving at Least One Drug in Part D
63%Patients 65 Years and Older
90% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Ohio
Lower avg

Schedule Two
Controlled Substances

18% of this provider’s 296 patients filled at least one prescription for a schedule two drug, compared to an average of 1%.

Schedule Three
Controlled Substances

10% of this provider’s 296 patients filled at least one prescription for a schedule three drug, compared to an average of 1%.

Risky Drugs to Seniors

0% of this provider’s 4,007 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 0%.

Brand Name Drugs

31% of this provider’s prescriptions were for brand-name drugs, compared to an average of 60%.

Prescription Price

$77 was the average price of a prescription from this provider, compared to $208 among peers.

Prescriptions per Patient

33 is the average number of prescriptions (including refills) per patient, compared to an average of 8.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Ohio
WARFARIN SODIUM 412 70 1 19
FUROSEMIDE 338 142 2 11
SPIRIVA 337 154 3 1
POTASSIUM CHLORIDE 274 95 4 28
OMEPRAZOLE 191 62 5 10
LEVOTHYROXINE SODIUM 191 88 5 15
METOPROLOL TARTRATE 185 90 7 30
HYDROCODONE-ACETAMINOPHEN 182 26 S3 8 21
ADVAIR DISKUS 157 61 9 2
AMLODIPINE BESYLATE 156 107 10 18
TRAMADOL HCL 147 69 11 47
SIMVASTATIN 144 91 12 22
GABAPENTIN 137 60 13 42
OXYCODONE HCL 131 0 S2 14 114
LANTUS 126 66 15 67
LISINOPRIL 115 82 16 24
PROAIR HFA 111 59 17 4
SPIRONOLACTONE 99 26 18 33
AZITHROMYCIN 97 70 19 6
CYMBALTA 94 20 20 126
OXYCODONE-ACETAMINOPHEN 93 11 S2 21 73
PREDNISONE 90 39 22 3
ALBUTEROL SULFATE 89 11 23 20
LEVETIRACETAM 87 14 24 128
KLOR-CON M10 87 48 24 128
METFORMIN HCL 86 44 26 40
COMBIVENT 85 43 27 9
LYRICA 84 11 28 131
FENTANYL 82 12 S2 29 133
CITALOPRAM HBR 80 36 30 48
HEPARIN SODIUM 77 41 31 135
DIGOXIN 76 37 32 136
ALLOPURINOL 75 46 33 86
LEVOFLOXACIN 73 22 34 34
FAMOTIDINE 73 39 34 84
NITROFURANTOIN MONO-MACRO 72 12 36 141
ENOXAPARIN SODIUM 66 0 37 119
KLOR-CON M20 64 24 38 80
CLONIDINE HCL 64 42 38 152
HYDROMORPHONE HCL 63 0 S2 40 154
CYCLOBENZAPRINE HCL 60 0 R 41 158
HYDROCHLOROTHIAZIDE 59 44 42 49
NIASPAN 58 19 43 161
AMOX TR-POTASSIUM CLAVULANATE 57 13 44 37
ATORVASTATIN CALCIUM 54 41 45 35
NEXIUM 53 23 46 44
METOCLOPRAMIDE HCL 51 0 47 169
MORPHINE SULFATE ER 50 0 S2 48 173
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on March 25, 2010.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.